Form D — Oaktree Life Sciences Income Fund (Parallel), L.P.
0002048690-25-000001 · filed 2025-01-29
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06c, 3C, 3C.7
- Total offering
- —
- Total sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Oaktree Life Sciences Income Fund (Parallel), L.P.
- CIK
- 2048690
- Entity
- Limited Partnership
- Jurisdiction
- CAYMAN ISLANDS
- Year incorporated
- 2024
- Address
- 333 S. GRAND AVENUE, 28TH FLOOR
LOS ANGELES, CA 90071 - Phone
- 213-830-6300
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
n/a Oaktree Life Sciences Income Fund GP, L.P. · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
n/a Oaktree Capital Management, L.P. · PromoterLos Angeles, CA Find on LinkedIn ↗
-
Howard Marks · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Bruce Karsh · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Sheldon Stone · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
John Frank · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Daniel Levin · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Robert O'Leary · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Todd Molz · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Armen Panossian · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
View original on SEC EDGAR.